SKI Market

Indian Indices

Sensex

78,214.30 648.14
( 0.84%)

Global Indices

Nasdaq

47,737.88 215.33
(0.45%)

Dow Jones

6,814.47 53.45
(0.79%)

Hang Seng

54,146.56 1,417.84
(2.69%)

Nikkei 225

10,249.54 -35.21
(-0.34%)

Forex

USD-INR

91.85 0.10
(0.11%)

EUR-INR

106.60 0.13
(0.12%)

GBP-INR

123.04 0.62
(0.51%)

JPY-INR

0.58 0.00
(-0.25%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Brooks Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

533543

INE650L01011

40.7226255

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BROOKS

26.32

172.91

EPS(TTM)

Face Value()

Div & Yield %

2.23

Back

Accedere reports consolidated net loss of Rs 0.01 crore in the December 2025 quarter

Jan 29,2026

Net loss of Accedere reported to Rs 0.01 crore in the quarter ended December 2025 as against net profit of Rs 0.03 crore during the previous quarter ended December 2024. Sales remain constant at Rs 0.73 crore in the quarter ended December 2025 and also during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	0.73	0.73	0
OPM %	4.11	16.44	-
PBDT	0.03	0.13	-77
PBT	-0.02	0.09	PL
NP	-0.01	0.03	PL

78,214.30 648.14 ( 0.84%)

47,737.88 215.33 (0.45%)

6,814.47 53.45 (0.79%)

54,146.56 1,417.84 (2.69%)

10,249.54 -35.21 (-0.34%)

91.85 0.10 (0.11%)

106.60 0.13 (0.12%)

123.04 0.62 (0.51%)

0.58 0.00 (-0.25%)